Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

R. Charles Nichols JrUniversity of Florida Proton Therapy Institute, Jacksonville, Florida, USACorrespondence[email protected]

Thomas J. GeorgeDepartment of Hematology and Medical Oncology, University of Florida, Gainesville and Jacksonville, Florida, USA

Robert A. Zaiden JrDepartment of Hematology and Medical Oncology, University of Florida, Gainesville and Jacksonville, Florida, USA

Ziad T. AwadDepartment of Surgery, University of Florida, Jacksonville, FL, USA

Horacio J. AsbunDepartment of Surgery, Mayo Clinic, Jacksonville, Florida, USA

Soon HuhUniversity of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Meng Wei HoUniversity of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Nancy P. MendenhallUniversity of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Christopher G. MorrisUniversity of Florida Proton Therapy Institute, Jacksonville, Florida, USA

bradford S. HoppeUniversity of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Your download is now in progress and you may close this window